Folia Pharmacologica Japonica
Online ISSN : 1347-8397
Print ISSN : 0015-5691
ISSN-L : 0015-5691
Reviews: Molecular Basis of Heart Failure and its Treatments
Effects of humoral factors on left ventricular remodeling under chronic heart failure
Makoto KODAMAHitoshi TACHIKAWATakeshi KASHIMURAManabu HAYASHITsuyoshi YOSHIDAHaruo HANAWAYoshifusa AIZAWAMikio NAKAZAWAKenichi WATANABE
Author information
JOURNAL FREE ACCESS

2004 Volume 123 Issue 2 Pages 63-70

Details
Abstract

Chronic heart failure is a slowly progressive disease. Hemodynamic deterioration activates various neuro-humoral factors and increases stresses, such as catecholamine, angiotensin II (AII), cytokines, endothelin, wall stress, ischemia, tachycardia, and oxidative stress. These factors affect the myocardium to cause phenotype switching, leading to ventricular remodeling. We investigated the effects of pharmacological blocking for neuro-humoral factors in rats with dilated cardiomyopathy. Experimental autoimmune myocarditis (EAM) was elicited in Lewis rats by immunization with cardiac myosin. After acute inflammation healed, rats were treated with angiotensin converting enzyme inhibitors (ACEI), type 1 AII receptor blockers, and amiodarone. These agents had favorable effects on hemodynamics and myocardial contractility, prevented fibrosis, suppressed the expression of ANP, and reversed phenotypic change of cardiac myosin. AII receptor blockers were less effective than ACEI. In order to prevent ventricular remodeling in chronic heart failure, wide and complete blocking of neuro-humoral factors is important.

Content from these authors
© 2004 by The Japanese Pharmacological Society
Previous article Next article
feedback
Top